Results 221 to 230 of about 314,176 (271)
Fostamatinib had 46% durable response, with 73% steroid reduction, in this multicentre retrospective study of refractory wAIHA/ES. Hypertension, gastrointestinal (GI) distress and neutropenia occurred in 23%. Only one patient required drug discontinuation and one patient dose reduction.
Jorge N. Ruiz Lopez +16 more
wiley +1 more source
Impact of post-COVID-19 syndrome on quality of life and functionality in ethnically diverse and vulnerable populations in the Amazon. [PDF]
de Paula MS +12 more
europepmc +1 more source
ABSTRACT Background Educational access is key in empowering persons living with intellectual disabilities. Nevertheless, internationally, Persons with Intellectual Disabilities continue to experience marginalization and discrimination in accessing higher education.
Denise De Souza +8 more
wiley +1 more source
Efficacy and safety of traditional Chinese medicine for post-COVID-19 syndrome: a systematic review and meta-analysis. [PDF]
Wang Y, Li X, Hui H, Yang D.
europepmc +1 more source
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody +5 more
wiley +1 more source
Autoimmune Rhombencephalitis as a Presentation of Post-COVID-19 Syndrome: A Case Report. [PDF]
Mohamed AS +5 more
europepmc +1 more source
ABSTRACT Aim To explore the perspectives of individuals with intellectual disabilities on post‐secondary education. Background Education is a fundamental human right that encourages personal growth, inclusion, and access to meaningful opportunities.
Thérèse Hennessy +2 more
wiley +1 more source
Dermatological complications due to post‑COVID‑19 syndrome: A systematic review. [PDF]
Cayón Figueroa BA +2 more
europepmc +1 more source
Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown +2 more
wiley +1 more source
Correction: Post-COVID-19 syndrome: Physical capacity, fatigue and quality of life. [PDF]
PLOS One Staff.
europepmc +1 more source

